Time for New Zealand to ban direct-to-consumer advertising of prescription medicines
New Zealand Medical Journal · 2023
DOI: 10.26635/6965.e1575 ↗Kurz gefasst
Editorial in der Zeitschrift New Zealand Medical Journal, 2023. Verfasst von David B Menkes und 2 weiteren Autor:innen. Beteiligte Einrichtung: The University of Auckland, Waikato Clinical Campus, Hamilton. Hauptthemen laut MEDLINE: Direct-to-Consumer Advertising, Prescription Drugs. Die Arbeit wurde bisher 2-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- The University of Auckland, Waikato Clinical Campus, Hamilton.
- The University of Sydney.
- York University, Toronto.
Zitieren
APA
Menkes, D. B., Mintzes, B., & Lexchin, J. (2023). Time for New Zealand to ban direct-to-consumer advertising of prescription medicines. New Zealand Medical Journal. https://doi.org/10.26635/6965.e1575
Vancouver
Menkes DB, Mintzes B, Lexchin J. Time for New Zealand to ban direct-to-consumer advertising of prescription medicines. New Zealand Medical Journal. 2023. doi:10.26635/6965.e1575
BibTeX
@article{Menkes2023,
author = {Menkes, David B and Mintzes, Barbara and Lexchin, Joel},
title = {Time for New Zealand to ban direct-to-consumer advertising of prescription medicines},
journal = {New Zealand Medical Journal},
year = {2023},
doi = {10.26635/6965.e1575}
}
EUVIMED